Reviews Intralipid 20%


No reviews yet.

Intralipid 20% Drug Description
Intralipid® 20%
(20% I.V. Fat Emulsion)
In Excel® Container
DRUG DESCRIPTION
INTRALIPID® 20% (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC
FAT EMULSION PREPARED FOR INTRAVENOUS ADMINISTRATION AS A SOURCE OF CALORIES
AND ESSENTIAL FATTY ACIDS. IT IS MADE UP OF 20% SOYBEAN OIL, 1.2% EGG YOLK PHOSPHOLIPIDS,
2.25% GLYCERIN, AND WATER FOR INJECTION. IN ADDITION, SODIUM HYDROXIDE HAS BEEN
ADDED TO ADJUST THE PH SO THAT THE FINAL PRODUCT PH IS 8. PH RANGE IS 6 TO 8.9.
The soybean oil is a refined natural product consisting of a mixture of neutral
triglycerides of predominantly unsaturated fatty acids with the following structure:







- ARE SATURATED AND UNSATURATED FATTY ACID RESIDUES.
The major component fatty acids are linoleic (44-62%), oleic (19-30%), palmitic
(7-14%), linolenic (4-11%) and stearic (1.4-5.5%)1. These fatty acids
have the following chemical and structural formulas:









PURIFIED EGG PHOSPHATIDES ARE A MIXTURE OF NATURALLY OCCURRING PHOSPHOLIPIDS
WHICH ARE ISOLATED FROM THE EGG YOLK. THESE PHOSPHOLIPIDS HAVE THE FOLLOWING
GENERAL STRUCTURE:









R1C- AND R2C- CONTAIN SATURATED AND UNSATURATED FATTY
ACIDS THAT ABOUND IN NEUTRAL FATS. R3 IS PRIMARILY EITHER THE CHOLINE
OR ETHANOLAMINE ESTER OF PHOSPHORIC ACID.







GLYCERIN IS CHEMICALLY DESIGNATED C3H8O3 AND IS A CLEAR COLORLESS, HYGROSCOPIC
SYRUPY LIQUID. IT HAS THE FOLLOWING STRUCTURAL FORMULA:







INTRALIPID® 20% (A 20% INTRAVENOUSA FAT EMULSION) HAS AN OSMOLALITY OF
APPROXIMATELY 350 MOSMOL/KG WATER (WHICH REPRESENTS 260 MOSMOL/LITER OF EMULSION)
AND CONTAINS EMULSIFIED FAT PARTICLES OF APPROXIMATELY 0.5 MICRON SIZE.
THE TOTAL CALORIC VALUE, INCLUDING FAT, PHOSPHOLIPID AND GLYCERIN, IS 2.0 KCAL
PER ML OF INTRALIPID® 20%. THE PHOSPHOLIPIDS PRESENT CONTRIBUTE 47 MILLIGRAMS
OR APPROXIMATELY 1.5 MMOL OF PHOSPHORUS PER 100 ML OF THE EMULSION.
THE PRIMARY CONTAINER IS MANUFACTURED FROM EXCEL® FILM, A POLYPROPYLENE
BASED MATERIAL COMPRISED OF THREE CO-EXTRUDED LAYERS.
THE PLASTIC CONTAINER IS MADE FROM MULTILAYERED FILM SPECIFICALLY DESIGNED
FOR PARENTERAL DRUGS. IT CONTAINS NO PLASTICIZERS AND EXHIBITS VIRTUALLY NO
LEACHABLES. THE SOLUTION CONTACT LAYER IS A RUBBERIZED COPOLYMER OF ETHYLENE
AND PROPYLENE. THE CONTAINER IS NONTOXIC AND BIOLOGICALLY INERT. THE CONTAINER-SOLUTION
UNIT IS A CLOSED SYSTEM AND IS NOT DEPENDENT UPON ENTRY OF EXTERNAL AIR DURING
ADMINISTRATION. THE CONTAINER IS OVERWRAPPED TO PROVIDE PROTECTION FROM THE
PHYSICAL ENVIRONMENT AND TO PROVIDE AN ADDITIONAL MOISTURE BARRIER WHEN NECESSARY.
1. PADLEY FB: "MAJOR VEGETABLE FATS," THE LIPID
HANDBOOK (GUNSTONE FD, HARWOOD JL, PADLEY FB, EDS.), CHAPMAN AND HALL LTD.,
CAMBRIDGE, UK (1986), PP. 88-9.Last reviewed on RxList: 7/30/2007




Intralipid 20% Drug Description
Intralipid® 20%
(20% I.V. Fat Emulsion)
In Excel® Container
DRUG DESCRIPTION
INTRALIPID® 20% (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC
FAT EMULSION PREPARED FOR INTRAVENOUS ADMINISTRATION AS A SOURCE OF CALORIES
AND ESSENTIAL FATTY ACIDS. IT IS MADE UP OF 20% SOYBEAN OIL, 1.2% EGG YOLK PHOSPHOLIPIDS,
2.25% GLYCERIN, AND WATER FOR INJECTION. IN ADDITION, SODIUM HYDROXIDE HAS BEEN
ADDED TO ADJUST THE PH SO THAT THE FINAL PRODUCT PH IS 8. PH RANGE IS 6 TO 8.9.
The soybean oil is a refined natural product consisting of a mixture of neutral
triglycerides of predominantly unsaturated fatty acids with the following structure:







- ARE SATURATED AND UNSATURATED FATTY ACID RESIDUES.
The major component fatty acids are linoleic (44-62%), oleic (19-30%), palmitic
(7-14%), linolenic (4-11%) and stearic (1.4-5.5%)1. These fatty acids
have the following chemical and structural formulas:









PURIFIED EGG PHOSPHATIDES ARE A MIXTURE OF NATURALLY OCCURRING PHOSPHOLIPIDS
WHICH ARE ISOLATED FROM THE EGG YOLK. THESE PHOSPHOLIPIDS HAVE THE FOLLOWING
GENERAL STRUCTURE:









R1C- AND R2C- CONTAIN SATURATED AND UNSATURATED FATTY
ACIDS THAT ABOUND IN NEUTRAL FATS. R3 IS PRIMARILY EITHER THE CHOLINE
OR ETHANOLAMINE ESTER OF PHOSPHORIC ACID.







GLYCERIN IS CHEMICALLY DESIGNATED C3H8O3 AND IS A CLEAR COLORLESS, HYGROSCOPIC
SYRUPY LIQUID. IT HAS THE FOLLOWING STRUCTURAL FORMULA:







INTRALIPID® 20% (A 20% INTRAVENOUSA FAT EMULSION) HAS AN OSMOLALITY OF
APPROXIMATELY 350 MOSMOL/KG WATER (WHICH REPRESENTS 260 MOSMOL/LITER OF EMULSION)
AND CONTAINS EMULSIFIED FAT PARTICLES OF APPROXIMATELY 0.5 MICRON SIZE.
THE TOTAL CALORIC VALUE, INCLUDING FAT, PHOSPHOLIPID AND GLYCERIN, IS 2.0 KCAL
PER ML OF INTRALIPID® 20%. THE PHOSPHOLIPIDS PRESENT CONTRIBUTE 47 MILLIGRAMS
OR APPROXIMATELY 1.5 MMOL OF PHOSPHORUS PER 100 ML OF THE EMULSION.
THE PRIMARY CONTAINER IS MANUFACTURED FROM EXCEL® FILM, A POLYPROPYLENE
BASED MATERIAL COMPRISED OF THREE CO-EXTRUDED LAYERS.
THE PLASTIC CONTAINER IS MADE FROM MULTILAYERED FILM SPECIFICALLY DESIGNED
FOR PARENTERAL DRUGS. IT CONTAINS NO PLASTICIZERS AND EXHIBITS VIRTUALLY NO
LEACHABLES. THE SOLUTION CONTACT LAYER IS A RUBBERIZED COPOLYMER OF ETHYLENE
AND PROPYLENE. THE CONTAINER IS NONTOXIC AND BIOLOGICALLY INERT. THE CONTAINER-SOLUTION
UNIT IS A CLOSED SYSTEM AND IS NOT DEPENDENT UPON ENTRY OF EXTERNAL AIR DURING
ADMINISTRATION. THE CONTAINER IS OVERWRAPPED TO PROVIDE PROTECTION FROM THE
PHYSICAL ENVIRONMENT AND TO PROVIDE AN ADDITIONAL MOISTURE BARRIER WHEN NECESSARY.
1. PADLEY FB: "MAJOR VEGETABLE FATS," THE LIPID
HANDBOOK (GUNSTONE FD, HARWOOD JL, PADLEY FB, EDS.), CHAPMAN AND HALL LTD.,
CAMBRIDGE, UK (1986), PP. 88-9.Last reviewed on RxList: 7/30/2007




Intralipid 20% Drug Description
Intralipid® 20%
(20% I.V. Fat Emulsion)
In Excel® Container
DRUG DESCRIPTION
INTRALIPID® 20% (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC
FAT EMULSION PREPARED FOR INTRAVENOUS ADMINISTRATION AS A SOURCE OF CALORIES
AND ESSENTIAL FATTY ACIDS. IT IS MADE UP OF 20% SOYBEAN OIL, 1.2% EGG YOLK PHOSPHOLIPIDS,
2.25% GLYCERIN, AND WATER FOR INJECTION. IN ADDITION, SODIUM HYDROXIDE HAS BEEN
ADDED TO ADJUST THE PH SO THAT THE FINAL PRODUCT PH IS 8. PH RANGE IS 6 TO 8.9.
The soybean oil is a refined natural product consisting of a mixture of neutral
triglycerides of predominantly unsaturated fatty acids with the following structure:







- ARE SATURATED AND UNSATURATED FATTY ACID RESIDUES.
The major component fatty acids are linoleic (44-62%), oleic (19-30%), palmitic
(7-14%), linolenic (4-11%) and stearic (1.4-5.5%)1. These fatty acids
have the following chemical and structural formulas:









PURIFIED EGG PHOSPHATIDES ARE A MIXTURE OF NATURALLY OCCURRING PHOSPHOLIPIDS
WHICH ARE ISOLATED FROM THE EGG YOLK. THESE PHOSPHOLIPIDS HAVE THE FOLLOWING
GENERAL STRUCTURE:









R1C- AND R2C- CONTAIN SATURATED AND UNSATURATED FATTY
ACIDS THAT ABOUND IN NEUTRAL FATS. R3 IS PRIMARILY EITHER THE CHOLINE
OR ETHANOLAMINE ESTER OF PHOSPHORIC ACID.







GLYCERIN IS CHEMICALLY DESIGNATED C3H8O3 AND IS A CLEAR COLORLESS, HYGROSCOPIC
SYRUPY LIQUID. IT HAS THE FOLLOWING STRUCTURAL FORMULA:







INTRALIPID® 20% (A 20% INTRAVENOUSA FAT EMULSION) HAS AN OSMOLALITY OF
APPROXIMATELY 350 MOSMOL/KG WATER (WHICH REPRESENTS 260 MOSMOL/LITER OF EMULSION)
AND CONTAINS EMULSIFIED FAT PARTICLES OF APPROXIMATELY 0.5 MICRON SIZE.
THE TOTAL CALORIC VALUE, INCLUDING FAT, PHOSPHOLIPID AND GLYCERIN, IS 2.0 KCAL
PER ML OF INTRALIPID® 20%. THE PHOSPHOLIPIDS PRESENT CONTRIBUTE 47 MILLIGRAMS
OR APPROXIMATELY 1.5 MMOL OF PHOSPHORUS PER 100 ML OF THE EMULSION.
THE PRIMARY CONTAINER IS MANUFACTURED FROM EXCEL® FILM, A POLYPROPYLENE
BASED MATERIAL COMPRISED OF THREE CO-EXTRUDED LAYERS.
THE PLASTIC CONTAINER IS MADE FROM MULTILAYERED FILM SPECIFICALLY DESIGNED
FOR PARENTERAL DRUGS. IT CONTAINS NO PLASTICIZERS AND EXHIBITS VIRTUALLY NO
LEACHABLES. THE SOLUTION CONTACT LAYER IS A RUBBERIZED COPOLYMER OF ETHYLENE
AND PROPYLENE. THE CONTAINER IS NONTOXIC AND BIOLOGICALLY INERT. THE CONTAINER-SOLUTION
UNIT IS A CLOSED SYSTEM AND IS NOT DEPENDENT UPON ENTRY OF EXTERNAL AIR DURING
ADMINISTRATION. THE CONTAINER IS OVERWRAPPED TO PROVIDE PROTECTION FROM THE
PHYSICAL ENVIRONMENT AND TO PROVIDE AN ADDITIONAL MOISTURE BARRIER WHEN NECESSARY.
1. PADLEY FB: "MAJOR VEGETABLE FATS," THE LIPID
HANDBOOK (GUNSTONE FD, HARWOOD JL, PADLEY FB, EDS.), CHAPMAN AND HALL LTD.,
CAMBRIDGE, UK (1986), PP. 88-9.Last reviewed on RxList: 7/30/2007




Intralipid 20% Drug Description
Intralipid® 20%
(20% I.V. Fat Emulsion)
In Excel® Container
DRUG DESCRIPTION
INTRALIPID® 20% (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC
FAT EMULSION PREPARED FOR INTRAVENOUS ADMINISTRATION AS A SOURCE OF CALORIES
AND ESSENTIAL FATTY ACIDS. IT IS MADE UP OF 20% SOYBEAN OIL, 1.2% EGG YOLK PHOSPHOLIPIDS,
2.25% GLYCERIN, AND WATER FOR INJECTION. IN ADDITION, SODIUM HYDROXIDE HAS BEEN
ADDED TO ADJUST THE PH SO THAT THE FINAL PRODUCT PH IS 8. PH RANGE IS 6 TO 8.9.
The soybean oil is a refined natural product consisting of a mixture of neutral
triglycerides of predominantly unsaturated fatty acids with the following structure:







- ARE SATURATED AND UNSATURATED FATTY ACID RESIDUES.
The major component fatty acids are linoleic (44-62%), oleic (19-30%), palmitic
(7-14%), linolenic (4-11%) and stearic (1.4-5.5%)1. These fatty acids
have the following chemical and structural formulas:









PURIFIED EGG PHOSPHATIDES ARE A MIXTURE OF NATURALLY OCCURRING PHOSPHOLIPIDS
WHICH ARE ISOLATED FROM THE EGG YOLK. THESE PHOSPHOLIPIDS HAVE THE FOLLOWING
GENERAL STRUCTURE:









R1C- AND R2C- CONTAIN SATURATED AND UNSATURATED FATTY
ACIDS THAT ABOUND IN NEUTRAL FATS. R3 IS PRIMARILY EITHER THE CHOLINE
OR ETHANOLAMINE ESTER OF PHOSPHORIC ACID.







GLYCERIN IS CHEMICALLY DESIGNATED C3H8O3 AND IS A CLEAR COLORLESS, HYGROSCOPIC
SYRUPY LIQUID. IT HAS THE FOLLOWING STRUCTURAL FORMULA:







INTRALIPID® 20% (A 20% INTRAVENOUSA FAT EMULSION) HAS AN OSMOLALITY OF
APPROXIMATELY 350 MOSMOL/KG WATER (WHICH REPRESENTS 260 MOSMOL/LITER OF EMULSION)
AND CONTAINS EMULSIFIED FAT PARTICLES OF APPROXIMATELY 0.5 MICRON SIZE.
THE TOTAL CALORIC VALUE, INCLUDING FAT, PHOSPHOLIPID AND GLYCERIN, IS 2.0 KCAL
PER ML OF INTRALIPID® 20%. THE PHOSPHOLIPIDS PRESENT CONTRIBUTE 47 MILLIGRAMS
OR APPROXIMATELY 1.5 MMOL OF PHOSPHORUS PER 100 ML OF THE EMULSION.
THE PRIMARY CONTAINER IS MANUFACTURED FROM EXCEL® FILM, A POLYPROPYLENE
BASED MATERIAL COMPRISED OF THREE CO-EXTRUDED LAYERS.
THE PLASTIC CONTAINER IS MADE FROM MULTILAYERED FILM SPECIFICALLY DESIGNED
FOR PARENTERAL DRUGS. IT CONTAINS NO PLASTICIZERS AND EXHIBITS VIRTUALLY NO
LEACHABLES. THE SOLUTION CONTACT LAYER IS A RUBBERIZED COPOLYMER OF ETHYLENE
AND PROPYLENE. THE CONTAINER IS NONTOXIC AND BIOLOGICALLY INERT. THE CONTAINER-SOLUTION
UNIT IS A CLOSED SYSTEM AND IS NOT DEPENDENT UPON ENTRY OF EXTERNAL AIR DURING
ADMINISTRATION. THE CONTAINER IS OVERWRAPPED TO PROVIDE PROTECTION FROM THE
PHYSICAL ENVIRONMENT AND TO PROVIDE AN ADDITIONAL MOISTURE BARRIER WHEN NECESSARY.
1. PADLEY FB: "MAJOR VEGETABLE FATS," THE LIPID
HANDBOOK (GUNSTONE FD, HARWOOD JL, PADLEY FB, EDS.), CHAPMAN AND HALL LTD.,
CAMBRIDGE, UK (1986), PP. 88-9.Last reviewed on RxList: 7/30/2007




Intralipid 20% Drug Description
Intralipid® 20%
(20% I.V. Fat Emulsion)
In Excel® Container
DRUG DESCRIPTION
INTRALIPID® 20% (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC
FAT EMULSION PREPARED FOR INTRAVENOUS ADMINISTRATION AS A SOURCE OF CALORIES
AND ESSENTIAL FATTY ACIDS. IT IS MADE UP OF 20% SOYBEAN OIL, 1.2% EGG YOLK PHOSPHOLIPIDS,
2.25% GLYCERIN, AND WATER FOR INJECTION. IN ADDITION, SODIUM HYDROXIDE HAS BEEN
ADDED TO ADJUST THE PH SO THAT THE FINAL PRODUCT PH IS 8. PH RANGE IS 6 TO 8.9.
The soybean oil is a refined natural product consisting of a mixture of neutral
triglycerides of predominantly unsaturated fatty acids with the following structure:







- ARE SATURATED AND UNSATURATED FATTY ACID RESIDUES.
The major component fatty acids are linoleic (44-62%), oleic (19-30%), palmitic
(7-14%), linolenic (4-11%) and stearic (1.4-5.5%)1. These fatty acids
have the following chemical and structural formulas:









PURIFIED EGG PHOSPHATIDES ARE A MIXTURE OF NATURALLY OCCURRING PHOSPHOLIPIDS
WHICH ARE ISOLATED FROM THE EGG YOLK. THESE PHOSPHOLIPIDS HAVE THE FOLLOWING
GENERAL STRUCTURE:









R1C- AND R2C- CONTAIN SATURATED AND UNSATURATED FATTY
ACIDS THAT ABOUND IN NEUTRAL FATS. R3 IS PRIMARILY EITHER THE CHOLINE
OR ETHANOLAMINE ESTER OF PHOSPHORIC ACID.







GLYCERIN IS CHEMICALLY DESIGNATED C3H8O3 AND IS A CLEAR COLORLESS, HYGROSCOPIC
SYRUPY LIQUID. IT HAS THE FOLLOWING STRUCTURAL FORMULA:







INTRALIPID® 20% (A 20% INTRAVENOUSA FAT EMULSION) HAS AN OSMOLALITY OF
APPROXIMATELY 350 MOSMOL/KG WATER (WHICH REPRESENTS 260 MOSMOL/LITER OF EMULSION)
AND CONTAINS EMULSIFIED FAT PARTICLES OF APPROXIMATELY 0.5 MICRON SIZE.
THE TOTAL CALORIC VALUE, INCLUDING FAT, PHOSPHOLIPID AND GLYCERIN, IS 2.0 KCAL
PER ML OF INTRALIPID® 20%. THE PHOSPHOLIPIDS PRESENT CONTRIBUTE 47 MILLIGRAMS
OR APPROXIMATELY 1.5 MMOL OF PHOSPHORUS PER 100 ML OF THE EMULSION.
THE PRIMARY CONTAINER IS MANUFACTURED FROM EXCEL® FILM, A POLYPROPYLENE
BASED MATERIAL COMPRISED OF THREE CO-EXTRUDED LAYERS.
THE PLASTIC CONTAINER IS MADE FROM MULTILAYERED FILM SPECIFICALLY DESIGNED
FOR PARENTERAL DRUGS. IT CONTAINS NO PLASTICIZERS AND EXHIBITS VIRTUALLY NO
LEACHABLES. THE SOLUTION CONTACT LAYER IS A RUBBERIZED COPOLYMER OF ETHYLENE
AND PROPYLENE. THE CONTAINER IS NONTOXIC AND BIOLOGICALLY INERT. THE CONTAINER-SOLUTION
UNIT IS A CLOSED SYSTEM AND IS NOT DEPENDENT UPON ENTRY OF EXTERNAL AIR DURING
ADMINISTRATION. THE CONTAINER IS OVERWRAPPED TO PROVIDE PROTECTION FROM THE
PHYSICAL ENVIRONMENT AND TO PROVIDE AN ADDITIONAL MOISTURE BARRIER WHEN NECESSARY.
1. PADLEY FB: "MAJOR VEGETABLE FATS," THE LIPID
HANDBOOK (GUNSTONE FD, HARWOOD JL, PADLEY FB, EDS.), CHAPMAN AND HALL LTD.,
CAMBRIDGE, UK (1986), PP. 88-9.Last reviewed on RxList: 7/30/2007





Other reviews about Intralipid 20% on wordpress

What is Omegaven?
  by mamarraine
In a previous post, we talked about the incredible team that takes care of patients like Sébastien who have short bowel syndrome. Today we'll take a look at […]


Nutrition
  by surgeryonline
Malnutrition In surgical practice malnutrition is common, being present before, or occurring after, operations in about 50per cent of patients, possibly more in some parts of the world. Preoperative malnutrition […]


Meeting Abstracts: 7th November 2008
  by Academic Paediatrics GBI
Modulation of mucosal immune responses to pneumococcal protein antigens in human NALT by TLR2 and TLR9 ligands Qibo Zhang1, Linda Bagrade2, Ed Clark1, James Paton4, Desmond Nunez 3, Adam […]


Going Up, Up, UP!
  by lhoham
Had ANOTHER beta this morning. The result was 4,766! I have to admit I was a bit surprised as my symptoms were not as severe yesterday and today. […]


Neither “low-fat” nor “high-fat” but the “right fat” for better implantation and pregnancy: omega-3
  by Robert Greene, M.D.
Food is not only fuel to burn but also sometimes the source of basic chemicals to make hormones and various other necessary chemicals for healthy living. When these […]


Food and hypersensitivity in functional dyspepsia
  by Indonesian Children
Gut 2002;51:i50-i53 © 2002 by Gut VISCERAL PERCEPTION    Food and hypersensitivity in functional dyspepsia   N W Read Correspondence to: Correspondence to: Professor N W Read, Centre for Human Nutrition, Coleridge House, Northern ABSTRACT   It has […]


An update on us:
  by Marion
I thought I’ll tell you all a bit more about what happened the last few days… I had some spotting every now and then since about 7 weeks and […]


Severe local anaesthetic toxicity
  by cambridgemedicine
Blog Post by Dr Natasha Elworthy FRCA, Specialty Trainee in Anaesthesia, Papworth Hospital NHS Foundation Trust, Cambridge and Dr Stephen T Webb MB BCh BAO FRCA EDIC, Consultant in Anaesthesia & Intensive Care Medicine, […]


Feeding Guidelines for Tiny Babies
  by Dr Phillip Gordon
Feeding guidelines for Tulane NICU tiny baby bundled care Benefits of Feeding Guidelines Increase mucosal growth Increase GI hormone release Improve motor function Decrease bacterial translocation Enhanced nursing, house staff recognition of abnormal GI […]


Come up and rest while we sort the lea
  by xaxtulsvsqse
If you publish this photostat, that will be it. I keep it only to safeguard myself, and to preserve a weapon which will always secure me from any […]



Other reviews about Intralipid 20% on web:

Learn about the prescription medication Intralipid 20% (20% I.V. Fat Emulsion), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Intralipid 20% (20% I.V. Fat Emulsion) Drug Information: Uses ...


Find lowest price for a Intralipid 20% prescription. Save up to 70% on drug prices at verified online pharmacies. Buy Intralipid 20% Online | Compare Intralipid 20% Prices & Save ...


Intralipid® 20% is also available in the following fill sizes (see package insert 335 809). 100 mL: 0338-519-48. 250 mL: 0338-519-02 . 500 mL: 0338-519-03 Intralipid Official FDA information, side effects and uses.


Get Intralipid 20% 250ml online. Chemist Direct, UK offers Prescriptions products at discounted prices. Buy Intralipid 20% 250ml, £15.54, pharmacy Products, Online Pharmacy


INTRALIPID® 10% INTRALIPID® 20% INTRALIPID® 30% : Pharmacia & Upjohn : Fat Emulsions : I.V. Nutrition Action And Clinical Pharmacology: Intralipid acts as an energy source ... RxMed: Pharmaceutical Information - INTRALIPID


Intralipid is a brand name for the first safe fat emulsion for human use, approved in 1962 in ... It is available in a 10%, 20% and 30% concentration. The 30% concentration is not ... Intralipid - Wikipedia, the free encyclopedia


INTRALIPID 20% IV Fat Emulsion. 250 mL fill, 250 mL container, NDC# 0338-0519-02 Baxter US Product Catalog - INTRALIPID 20% IV Fat Emulsion


Intralipid 10 % = 1.1 Kcal/ml. Intralipid 20 % = 2.0 Kcal/ml. Intralipid 20% 1.2 ml x 24 hours = 28.8 ml/day. 28.8 ml x 2 Kcal/ml = 57.6 Kcal/day from Intralipid Pediatric Hyperalimentation Calculations


Note: Amino Acid Injection, (Novamine® 8.5, 11.4 or 15% or 8.5 Travasol® 8.5 or 15% without electrolytes), Dextrose Injection and Intralipid® 20% may be simultaneously ... Intralipid Dosage - Drugs.com


Intralipid® 10% IV Fat: 1A6013: 1A6013: 0338-0490-03: 500: 8.0: 260: 1100: 10: Intralipid® 20% IV Fat: 1A6022: 1A6022: 0338-0491-02: 250: 8.0: 268: 2000: 10: 1A6023: 1A6023: 0338-0491-03 Cardinal Health:Intralipid® IV Fat Emulsions





Featured Reviews

Reviews Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Solution

Cortisporin Otic Solution Drug Description CORTISPORIN Otic Solution (neomycin and polymyxin B sulfates and hydrocortisone) Otic Solution, USP DRUG DESCRIPTION Cortisporin Otic Solution (neomycin and polymyxin B sulfates and hydrocortisone...
Read More  |  Review This
Reviews Constantin Ferseta

that's all i can say about ferseta e-consulting company emarketing courses. WOW. Big BOLD WOW. Very interesting, with incredible ROI. I would recommend them to everybody....
Read More  |  Review This
Reviews Numorphan

Numorphan Drug Description NUMORPHAN® (oxymorphone hydrochloride) Injection, USP (oxymorphone hydrochloride) Suppositories, USP Opioid Analgesic DRUG DESCRIPTION NUMORPHAN (oxymorphone hydrochloride, USP), a semi-synthetic opioid...
Read More  |  Review This
Reviews Carbinoxamine Maleate and Pseudoephedrine HCl

Rondec Drug Description Rondec® Syrup (chlorpheniramine maleate and phenylephrine hydrochloride) Syrup DRUG DESCRIPTION Rondec® Syrup is a sugar-free, alcohol-free, bubblegum-flavored syrup for oral administration for adults and...
Read More  |  Review This
Reviews Acrivastine and Pseudoephedrine

Semprex D Drug Description SEMPREX-D (acrivastine and pseudoephedrine hydrochloride) Capsule DRUG DESCRIPTION What are the possible side effects of acrivastine and pseudoephedrine (Semprex-D)? Get emergency medical help if you...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....